GSK (LSE:GSK) shares have edged slightly lower as investors digest recent trading activity and look for new signals on the company’s next move. Over the past month, the stock has delivered a 12% gain, ...

GSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over ...

GSK GSK stock has risen 18.6% in the past three months. The price recovery was backed by strong third-quarter results, ...

GSK committed $270 million up front in recent months to gain access to early-stage assets in the class of cancer therapies known as antibody drug conjugates, or ADCs. The deals are part of a broad ...

CHICAGO--(BUSINESS WIRE)--BDO USA, LLP, one of the nation’s leading accounting and consulting firms, today announced an expansion of its South Florida practice through the addition of just over 100 ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026. He joined GSK in 2017 and is currently Chief ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

GSK shares best performer on London's stock market Deal reflects desire to avoid protracted litigation - GSK Zantac wiped almost $40 bln off drugmakers' shares last year June 23 (Reuters) - (This June ...

Sept 26 (Reuters) - Britain's GSK (GSK.L), opens new tab has appointed its first female chief financial officer, Julie Brown, to succeed Iain Mackay, as the drugmaker focuses on its core ...